MEGAN GIETZEN: Open Payments
NPI 1053832006 · DICKINSON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 11 payments from 6 companies in 2025. Trend: 2023 $121 · 2024 $310 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| Astellas Pharma US Inc | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Lilly USA, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Wegovy, Veozah, Sotyktu, ZEPBOUND, Ozempic, TRINTELLIX.
Industry payments across ND — which companies pay providers there.
